clinical trial · NCT07311369
Evaluate the Safety and Efficacy of HL-1186 Tablet for Postoperative Pain Management in Abdominal Surgery
Shanghai Yidian Pharmaceutical Technology Development Co., Ltd.·phase2·recruiting·n = 40
Moderate to Severe Acute Postoperative PainHL-1186HL-1186 placebo
brief summary
This is a multiple-center, randomized, double-blind, placebo-controlled study design evaluating the safety, efficacy, and pharmacokinetics (PK) parameter of HL-1186 tablet for postoperative pain management in abdominal surgery.
started
Dec 1, 2025
primary completion
Feb 1, 2026
completion
Mar 1, 2026
last updated
Dec 30, 2025
official title
A Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel-group Phase Ⅱa Study to Evaluate the Safety and Efficacy of HL-1186 Tablets for Postoperative Pain Management in Abdominal Surgery
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol